Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02539394
Other study ID # 2014-145
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2015
Est. completion date November 12, 2021

Study information

Verified date June 2023
Source Hospital for Special Surgery, New York
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine what effect intraoperative topical steroids have on reducing swallowing difficulty following Anterior Cervical Discectomy and Fusion surgery.


Description:

Background: Dysphagia is a serious post-operative concern in patients following anterior cervical surgery. Although many experts have acknowledged that dysphagia is often incompletely understood and defined, there is a significant amount of literature to support the significance of this clinical entity. This is the first randomized study to examine the use of topical steroids for the prevention of dysphagia postoperatively after anterior cervical discectomy and fusion. Study Design: This study is a single site, double blinded randomized control trial. All individuals undergoing 2-4 level ACDF that meet the inclusion criteria will be randomized to either: 1. treatment arm or 2. control arm. Both arms will undergo their planned surgeries and will receive the exact same procedure and standard of care as if they were not enrolled in a study. The only difference is that the treatment arm will receive 40 mg of Methylprednisolone Acetate delivered with one Hemostatic Matrix Kit injectable delivery vehicle prior to closure in the prevertebral soft tissues. The control group will receive only Hemostatic Matrix Kit prior to closure in the prevertebral soft tissues. Outcomes: Patients will be asked to fill out questionnaires that assess dysphagia, general swallowing difficulty, and how neck pain impacts their quality of life. Additionally Radiographic images will be obtained at set time points to evaluate soft tissue inflammation and bony fusion.


Recruitment information / eligibility

Status Completed
Enrollment 128
Est. completion date November 12, 2021
Est. primary completion date November 12, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Any patient > 18 years undergoing a 2-4 level Anterior Cervical Discectomy and Fusion Exclusion Criteria: - Patients undergoing revision surgery - Pediatric patients - Trauma patients with cervical spine fractures - Patients with cancer - Patients with active infection - Patients with a known allergy to Methylprednisolone Acetate - Patients who refuse to participate - Non English speakers

Study Design


Intervention

Drug:
Methylprednisolone Acetate
Methylprednisolone Acetate is a corticosteroid known to reduce swelling and inflammation.
Other:
Hemostatic Matrix Kit
Hemostatic Matrix Kits help prevent uncontrollable bleeding in a operative site during a procedure.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hospital for Special Surgery, New York

Outcome

Type Measure Description Time frame Safety issue
Primary Degree of Dysphagia Patients Experience (Burden) SWAL-QOL survey - Burden domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Eating Desire) SWAL-QOL survey - Eating desire domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Eating Duration) SWAL-QOL survey - Eating duration domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Food Selection) SWAL-QOL survey - Food Selection domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Communication) SWAL-QOL survey - Communication domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Fear Swallow) SWAL-QOL survey - Fear swallow domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Social) SWAL-QOL survey - Social domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Mental) SWAL-QOL survey - Mental domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Sleep) SWAL-QOL survey - Sleep domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Primary Degree of Dysphagia Patients Experience (Fatigue) SWAL-QOL survey - Fatigue domain Score ranges between 0 and 100 (worst-best) Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Patient Reported Swallowing Difficulty Over 1 Year The Eating Assessment Tool (EAT-10) is used to screen for self-perceived oropharyngeal dysphagia (OD) in community-dwelling elders. A summated EAT-10 total score ranges from 0 to 40, with a score = 3 indicative of OD.
Modified Eat-10 : Eat-10 questionnaire without questions 1 ("My swallowing problem has caused me to lose weight") and 2 ("My swallowing problem interferes with my ability to go out for meals") to be applicable during hospitalization.
Eat-10 interpretation: Score ranging from 0 to 40 (best-worst)
each question response is 0-4, 0=no problem and 4=severe problem; score is a summation of each question's response Modified EAT-10 interpretation: Score ranging from 0 to 32 (best-worst)
each question response is 0-4, 0=no problem and 4=severe problem; score is a summation of each question's response
Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Patients' Bazaz Dysphagia Score - Liquid Bazaz dysphagia scale defines dysphagia as none, mild, moderate and severe, depending on patients' symptoms with solid and liquid foods. Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Patients' Bazaz Dysphagia Score - Solid Bazaz dysphagia scale defines dysphagia as none, mild, moderate and severe, depending on patients' symptoms with solid and liquid foods. Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Patients' Neck Disability Neck Disability Index (NDI) Range from 0 to 100 (best-worst) Pre-Op, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Patients' Pain Scores on the Visual Analog Scale - Neck Pain Visual Analog Scale (VAS) - Neck pain Range from 0 to 100 (best-worst) Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Patients' Pain Scores on the Visual Analog Scale - Left Arm Pain Visual Analog Scale (VAS) - Left arm pain Range from 0 to 100 (best-worst) Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Patients' Pain Scores on the Visual Analog Scale - Right Arm Pain Visual Analog Scale (VAS) - Right arm pain Range from 0 to 100 (best-worst) Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Change in Pre-vertebral Soft Tissue Swelling Over 1 Year We are unable to report this outcome measure because soft tissue swelling was not assessed. The PI deemed it would not be included for this study as there is not a clinical or research standard to do so, nor is there normative data over time to compare against. Thus, data were not collected. Pre-Op, Post-Op Day 1, Week 4-6, 3 Months, 6 Months, 12 Months
Secondary Fusion Rate Flex-Ex X-rays
Bony bridging on a CT scan
Obvious bony remodeling on lateral X-ray
12 Months
Secondary Adverse Event Adverse Event (AE) following surgical treatment.
Adverse event were classified by severity based on the AO-ISSG criteria and treatment required:
Mild: Observed, medication, consult, X-ray. Essentially any management that was quick and easy and could be done at bedside Moderate: ICU admission, re-intubation, complication that had a documented prolonged hospital stay, medical procedure (such as flexible endoscopy), re-presentation to ED Severe: Inpatient re-admission, return to OR for any reason, mortality, failed OR.
AE were also categorize as Surgery-site related or unrelated adverse event. Finally, AE were also categorize as potentially related to steroid use (example: leukocytosis, pseudoarthrosis, or wound complications)
12 month
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03711474 - Dysphagia Following Anterior Cervical Spine Surgery; Single Dose Steroid vs Saline (DysDexVSSal) Phase 4
Enrolling by invitation NCT04074356 - Non-invasive Markers of Esophageal Function in Adults N/A
Suspended NCT04349462 - Post Critical Illness Dysphagia in the Intensive Care Unit N/A
Not yet recruiting NCT05982977 - Study on the Effect Mechanism of Acupuncture Combined With Swallowing Training in Oral Dysphagia of Stroke N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Active, not recruiting NCT03455608 - PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer N/A
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Recruiting NCT03682081 - Interventions for Patients With Alzheimer's Disease and Dysphagia N/A
Completed NCT05700838 - Refining Cough Skill Training in Parkinson's Disease and Dysphagia Phase 1
Not yet recruiting NCT04064333 - Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care N/A
Not yet recruiting NCT02724761 - Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion N/A
Completed NCT02927691 - Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Phase 2
Completed NCT01919112 - Fostering Eating After Stroke With Transcranial Direct Current Stimulation N/A
Completed NCT01370083 - Tongue Pressure Profile Training for Dysphagia Post Stroke Phase 2
Withdrawn NCT01200147 - Effectiveness of Rupture of Schatzki's Ring Using Biopsy Forceps Versus SIngle Dilation N/A
Completed NCT01723358 - Neuromuscular Electrical Stimulation (NMES) Treatment Technique Therapy in the Management of Young Infants With Severe Dysphagia Phase 2
Completed NCT00570557 - Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia N/A
Recruiting NCT00166751 - Sonographic Assessment of Laryngeal Elevation N/A
Completed NCT01476241 - Percutaneous Endoscopic Gastrostomy Tube Placement by Otorhinolaryngologist N/A
Completed NCT00717028 - Functional Endoscopic Evaluation of Swallowing N/A